API
< Back to all clusters
[HEALTH] · Italy · 2 sources

started · updated

Italy reports first penicillin-resistant Group B Streptococcus case

Health authorities in Piacenza, Italy, have identified the first domestic case of Group B Streptococcus (Streptococcus agalactiae) resistant to penicillin. The strain was isolated in February 2026 from an adult patient's blood analysis by the Ausl of Piacenza. Laboratory tests, confirmed by the Istituto Superiore di Sanità (ISS), revealed resistance to other antibiotics including erythromycin, tetracycline, and levofloxacin.

The ISS reported that while antibiotic resistance rates in Italy remain high, there are some signs of improvement. In 2025, there were 4,004 reported cases of bacteremia caused by carbapenem-resistant Enterobacteriaceae. Additionally, genomic surveillance has documented the spread of a high-risk, multidrug-resistant clone of Klebsiella pneumoniae (ST6668) across eight Italian regions and five European countries: France, Germany, Denmark, the Netherlands, and Romania.

Experts emphasize the importance of responsible antibiotic use and enhanced monitoring to protect vulnerable populations, such as infants and the elderly. The World Health Organization previously classified penicillin-resistant Group B Streptococcus as a medium-priority pathogen in 2024.

Entities

Ausl di Piacenza · European Centre for Disease Prevention and Control · Istituto Superiore di Sanità · Piacenza · World Health Organization